A Randomized Controlled Trial to Increase Breast Cancer Screening Uptake

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age44-69
SponsorChinese University of Hong Kong

About this trial

Breast cancer (BC) is the fifth leading cause of cancer deaths in women worldwide. In Hong Kong (HK), BC is the most common cancer, ranking third in cancer deaths among females. International guidelines advocate regular mammographic screening for women aged 40-50 to 69-74, reducing BC mortality by 20%.

The success and effectiveness of an organized cancer screening program are largely dependent on high adherence or uptake rates. However, nonadherence to BC screening is common and the suboptimal uptake rate remains a challenge, particularly in Asian countries.

Conventional interventions are effective in increasing mammographic screening uptake but are time-consuming, labor-dependent, and expensive. Mobile messenger chatbots are a potential cost-saving tool for enhancing BC screening uptake because they involve only a one-off development cost and a small maintenance cost . Currently, most studies evaluating the effectiveness of mobile health interventions in improving mammography screening uptake have been conducted in Western populations . Health-seeking behaviors for cancer screening in the Chinese population differ from those of Caucasians because of differences in culture, health beliefs, and education, especially regarding breast-related diseases. Chinese women often feel embarrassed when talking with healthcare workers in person about breast health. Communicating with a fully automated chatbot can minimize embarrassment. Additionally, linguistically and culturally tailored interventions are effective in increasing cancer screening rates in the Chinese population.

However, studies evaluating combined theory-based mHealth interventions to enhance BC screening uptake are scarce. Two theory-based WhatsApp chatbots were developed to promote CRC screening, and the longitudinal repeat fecal immunochemical test (FIT) adherence rate of a population-based CRC screening program in HK. These two chatbots used in investigator's previous studies had designs similar to that of the proposed chatbot, except for the health education materials. The chatbot design can be adopted directly with minor modifications to the workflow, replacement of content from CRC screening-related to BC screening-related, and culturally modified education materials. Consequently, the investigators can develop a new chatbot for this study at a lower cost and in a shorter time.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

asymptomatic Chinese Women

44-69 years old

eligible to enroll in a government-subsidized risk-stratified BC screening program

ability to read Chinese

Disqualifiers

moderate- or high-risk women as defined by the local risk-stratified BC screening program

inability to provide informed consent

incomplete conversation with the chatbot.

Trial design

Design model

Parallel

Treatments tested in this trial

  • WCI

    Other intervention

    The WCI group will receive automated messages based on the Health Belief Model (HBM) and Protection Motivation Theory (PMT), including personalized risk assessments, educational videos featuring medical professionals and relatable scenarios, and tailored prompts to encourage mammographic screening.

Treatment groups

470 Participants
are divided into 2 treatment groups
Group A: WCIExperimental treatment 1 intervention
Group B: STRNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

BCS uptake rate

The primary outcome is the BC screening uptake rate, defined as participation in and completion of mammographic screening within three months after the intervention.

Time frame
Within three months after the intervention

Secondary outcomes

1

BCS uptake rate

BC screening uptake rate within six months after the intervention

Time frame
Six months after the intervention
2

Risk factors related to BCS non-adherence by interview

Risk factors associated with breast cancer screening non-adherence will be collected by focused group discussion

Time frame
Six months after the intervention
3

Mammography results

Number of positive mammography results of subjects who completed mammography

Time frame
Six months after the intervention
4

Mammograph breast biopsy rate

Uptake rate of subsequent breast biopsy for those with positive mammographic results

Time frame
Six months after the intervention

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: